Alanyl-glutamine in peritoneal dialysis fluids - a randomized controlled phase I/II trial
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57070
下载链接
链接失效反馈官方服务：
资源简介：
In this open-label randomized controlled phase I/II trial, 20 stable peritoneal dialysis patients underwent two 4 h dwells with acidic glucose-based PDF, with and without 8 mM alanyl-glutamine (AlaGln) in a cross-over design. Unsupervised hierarchical clustering of transcriptomics data suggested specific effects of AlaGln in patients who had previously suffered from peritonitis. Expression profiles could be generated from 3 patients' RNA under both treatment conditions in the study.
创建时间：
2020-01-25
